Dr. Jürg Zimmermann      CML     Chronic Myeloid Leukemia

"Dr. Jürg Zimmermann, a medicinal chemist, is the chemical inventor of the compound STI571 also called Gleevec''   
Extract of Novartis    

 
​

VIDEOS

Jürg Zimmermann & team - new treatment for Chronic Myelogenous Leukaemia
May 5, 2009, European Patent Office

Jürg Zimmermann - Drug against chronic myelogenous leukaemia - Interview
May 5, 2009, European Patent Office

​Jürg Zimmermann - Drug against chronic myelogenous leukaemia - European Inventor Award
April 29, 2009, European Patent Office

​                                     See also  The Story of Gleevec